Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2004 February;56(1) > Minerva Pediatrica 2004 February;56(1):63-72

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,764


eTOC

 

REVIEWS  


Minerva Pediatrica 2004 February;56(1):63-72

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

The role of radiofrequency ablation for pediatric supraventricular tachycardia

Campbell R. M., Strieper M. J., Frias P. A.


PDF  


Radiofrequency ablation has become frontline therapy for many pediatric patients with common supraventricular tachycardia (SVTs). Rather than long-term treatment with medications, radiofrequency ablation offers the possibility of ''cure'' for certain SVT substrates. The decision to perform radiofrequency ablation should be made after full disclosure with the patient and parents about radiofrequency ablation (RFA) benefits and risk, alternative therapies, and the natural history of the SVT. This paper presents a discussion about the current status of RFA and common pediatric SVTs, as well as, discussing evolving RFA issues and indications.

top of page

Publication History

Cite this article as

Corresponding author e-mail